Epidemiologic status of bladder cancer in Shiraz, Southern Iran

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 5, 2011, Pages 1323-1327

  Salehi, Alireza ^a   Khezri, Abdul Aziz ^b   Malekmakan, Leila ^c   Aminsharifi, Alireza ^d  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d NONE

Author keywords

Bladder cancer; Epidemiology; Iran; Shiraz; Transitional cell carcinoma

Indexed keywords

EID: 84857957164     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ahmad E, Ghasemkhani O, Dastoori P (2003). Recurrence rate and prognostic factors of superficial bladder cancer in Shiraz Shahid Faghihi Hospital during the years 1998-2001. Journal of Zanjan University of Medical Sciences & Health Services, 11, 7-1.
2. Aliasgari MA, Kaviani A, Gachkar L, et al (2004). Is bladder cancer more common among opium addicts? Urol J, 1, 253-5.
3. Azizi F, Janghorbani M, Hatami H (2010). Bladder cancer. In 'Epidemiology and Control of Common Diseases in Iran', Eds Azizi T and Aghaabasloo M. Khosravi Press, Tehran pp 282-9.
4. Badar F, Sattar A, Meerza F, Irfan N, et al (2009). Carcinoma of the urinary bladder in a tertiary care setting in a developing country. Asian Pac J Cancer Prev, 10, 449-52.
5. Behmard S, Sadeghi A, Mohareri MR, et al (1981). Positive association of opium addiction and cancer of the bladder. Acta Cytol, 25, 142-6.
6. Bellmunt J, Guix M (2010). New agents for bladder cancer. Annals of Oncology, 21, 56-8.
7. Boyle P, Levin B (2008). World Cancer Report, IARC Press; pp 444-446.
8. Buchner FL, Bueno-de-Mesquita HB, Ros MM, et al (2010). Variety in vegetable and fruit consumption and risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer, 1-9.
9. Campbell W (2007). Urothelial Tumors of the Bladder. In 'Urology'. Eds Kavoussi LR, Novick AC, Partin AW, Peters CA, Wein AJ. Saunders Elsevier, Philadelphia pp 2407-2446.
10. Carel R, Levitas-Langman A, Kordysh E, et al(1999). Casereferent study on occupational risk factors for bladder cancer in southern Israel. Int Arch Occup Environ Health, 72, 304-8.
11. Eslami G, Golshani M, Rakhshan M, et al (2008). PCR of Human Papillomavirus in patients with bladder cancer and control group. Journal of the Shaheed Beheshti University of Medical Sciences And Health Services, 31, 339-43.
12. Farahmand M, Khademolhosseini F, Medhati1 M, et al (2009). Trend of Bladder Cancer in Fars Province, Southern Iran, 2002-2006. IRCMJ, 11, 470-2.
13. Gaertner RR, Thériault GP (2002). Risk of bladder cancer in foundry workers: a meta-analysis. Occup Environ Med, 59, 655-63.
14. Hosseini SY, Safarinejad MR, Amini E, et al (2010). Opium consumption and risk of bladder cancer: A case-control analysis. Urol Oncol, 28, 610-6.
15. Kellen E, Zeegers M, Paulussen A, et al (2006). Fruit consumption reduces the effect of smoking on bladder cancer risk. The Belgian case control study on bladder cancer. Int J Cancer, 15, 2572-8.
16. Kolahdoozan SH, Sadjadi AR, Amir Reza Radmard AR, et al (2010). Five Common Cancers in Iran. Arch Iran Med, 13, 143-6.
17. Konety BR, Carroll PR (2008). Urothelial Carcinoma: Cancers of the Bladder, Ureter, & Renal Pelvis. In 'Smiths General Urology', Eds Tanagho E and Mc Aninch JW. Lang Medical Books/McGraw- Hill, New York pp 324-46.
18. Madeb R, Messing EM (2004). Gender, racial and age differences in bladder cancer incidence and mortality. Urol Oncol, 22, 86-92.
19. Nourbakhsh A, Mohseni1 MG, Hatmi ZN (2006). Opium use in transitional cell carcinoma of the urinary bladder. Acta Medica Iranica, 44, 263-7.
20. Oosterhuis JW, Schapers RF, Janssen-Heijnen ML, et al (2002). Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems. J Clin Pathol, 55, 900-5.
21. Report of National Cancer Registration Iran (2007-2008). Islamic Republic of Iran. Ministry of Health and Medical Education, Office Health Deputy, Center for Disease Control and Prevention.
22. Safaie A (2002). Clinical stydy-Evaluation of pathological picture of bladder cancer in governmental hospital in Shiraz University of Medical Sciences, Shiraz, Iran in 5 recent years. [Disssertation]. Shiraz University of Medical Sciences, Shiraz, Iran.
23. Samanic C, Kogevinas M, Dosemeci M, et al (2006). Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev, 15, 1348-54.
24. Sedghi M (1994). Evaluation of bladder cancer in governmental hospital in Shiraz University of Medical Sciences, Shiraz, Iran. [Disssertation]. Shiraz University of Medical Sciences, Shiraz, Iran.
25. Scelo G, Brennan P (2007). The epidemiology of bladder and kidney cancer. Nat Clin Pract Urol, 4, 205-17.
26. Schned AR, Andrew AS, Marsit CJ, et al (2008). Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States. Scand J Urol Nephrol, 42, 237-42.
27. Soofi Majidpour H, Rahimi E, Malekpour MH (2001). The incidence rate of bladder cancer and demographic characteristics of the patients in Kurdistan province form year 1994 to 1999. Scientific Journal OF Kurdistan University of Medical Sciences, 5, 22-6.
28. Tanaka N, Kikuchi E, Matsumoto K, et al (2011). Frequency of Tumor Recurrence: A Strong Predictor of Stage Progression in Initially Diagnosed Nonmuscle Invasive Bladder Cancer. J Urol, 185, 450-5.
29. Villares da Costa LA, Wroclawski ML, Tobias-Machado M, et al (2008). Non-occupational risk factors for bladder. Einstein, 6, 507-10.
30. Vineis P (1994). Epidemiology of cancer from exposure to arylamines. Environ Health Perspect, 102, 7-10.
31. Yavari P, Sadrolhefazi B, Mohagheghi MA, et al (2009). A descriptive retrospective study of bladder cancer at a hospital in Iran (1973-2003). Asian Pac J Cancer Prev, 10, 681-4.
32. Yin H, Leong AS (2004). Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ ISUP system by immunophenotyping and follow-up. Am J Clin Pathol, 121, 679-87.
33. Zeegers MP, Dorant E, Goldbohm RA, et al (2001). Are coffee, tea, and total fluid consumption associated with bladder cancer risk? Cancer Causes Control, 12, 231-8.
34. Zeegers MP, Kellen E, Buntinx F, et al(2004). The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol, 21, 392-401.